S
Synlogic
SYBX
1.68000
USD
-0.01
(-0.59%)
مغلق
حجم التداول
112
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
17,310,241
الأخبار
العنوان: Synlogic
القطاع: Healthcare
الصناعة: Biotechnology
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformativetreatments for serious diseases.